Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials
A listing of Chronic Obstructive Pulmonary Disease (COPD) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Found 247 clinical trials
COPD Exacerbation Research Study
Looking for patients at least 40 years of age who have been diagnosed with COPD and recently had several events of worsening of symptoms.
- 133 views
- 23 Nov, 2020
- 1 location
NO 0050-0637
ICON Early Phase Services is conducting a non-interventional device research study adults age 40+ who are either healthy, or, have chronic obstructive pulmonary disease (COPD). This study is being
- 613 views
- 23 Nov, 2020
- 1 location
Add on treatment for COPD for patients who experience frequent exacerbations
Current or former smokers who are diagnosed with COPD and experienced at least 2 exacerbations- worsening of symptoms requiring steroid treatment or hospitalization despite being on multiple inhaler medications may qualify for this study involving benralizumab subcutaneous injections compared to placebo injections, initially every 4 weeks, then every 8 weeks …
- 0 views
- 09 Jun, 2022
- 1 location
Moderate to Severe COPD
Phase: IIITime Frame: 18 monthsAge requirements: 40 to 85 years of age
- 0 views
- 05 Sep, 2023
- 1 location
COPD (Chronic Obstructive Pulmonary Disease)
COPD (Chronic Obstructive Pulmonary Disease)
- 442 views
- 23 Nov, 2020
- 1 location
A 24-week treatment, multi-center, randomized, double-blind, double-dummy, parallel group study to compare Umeclidinium/Vilanterol, Umeclidinium, and Salmeterol in subjects with chronic obstructive pulmonary disease (COPD)
pulmonary disease (COPD)
- 615 views
- 25 Mar, 2021
- 1 location
A Randomized, double-blind, parallel-group, 12-week, chronic-dosing, multi-center study to assess the efficacy and safety of PT010 compared to PT009 in subjects with moderate to very severe chronic obstructive pulmonary disease (COPD).
obstructive pulmonary disease (COPD).
- 548 views
- 25 Mar, 2021
- 1 location
Randomized, Double-blind, Placebo-controlled, Parallel Group Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab (Anti-IL-33 mAb) in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)
This is a Phase 3, Randomized, Double-Blind, Placebo-Controlled study to assess the efficacy of itepekimab compared with placebo on the annualized rate of acute moderate-or-severe COPD exacerbations and pulmonary function in former smokers with moderate to severe COPD.
- 0 views
- 07 Jul, 2023
- 1 location
A Phase III, 52-week, Multinational, Multicenter, Randomized, Double-blind, 2-arm Parallel Group Study Comparing Efficacy, Safety and Tolerability of the Fixed Dose Triple Combination of Beclomethasone Dipropionate Plus Formoterol Fumarate Plus Glycopyrronium Bromide (CHF 5993) With the Fixed Dose Dual Combination of Beclomethasone Dipropionate Plus Formoterol Fumarate (CHF 1535), Both Administered Via pMDI in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
The purpose of this study is to compare CHF 5993 with CHF 1535 in improving lung function, reducing moderate and severe COPD exacerbations, and other clinical efficacy and safety outcomes in the target subject population.
- 0 views
- 07 Jul, 2023
- 1 location
Role of Genetic Factors in the Pathogenesis of Lung Disease
This study is designed to evaluate the genetics involved in the development of lung disease by surveying genes involved in the process of breathing and examining the genes in lung cells of patients with lung disease. The study will focus on defining the distribution of abnormal genes responsible for processes …
- 358 views
- 23 Nov, 2020
- 1 location